In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”, defined below) held in the last 24 months (see below for definitions). Please note that first authors were required to collect and submit disclosure information on behalf all other authors/contributors, if applicable.

• Ineligible Company: The ACCME defines an “ineligible company” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.
• Financial Relationships: Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit.  Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.
• Conflict of Interest: Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of an ineligible company with which he/she has a financial relationship.

The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity.  Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.

• Describe the updates introduced in the 9th Edition TNM Staging System for pleural mesothelioma.
• Apply the 9th Edition TNM criteria in clinical and pathologic evaluation to accurately assign stage groups.
• Integrate staging insights into patient care to guide therapy selection and improve prognostic assessment.

Contact

• For questions regarding the course content, please contact learning@facs.org.
• For general questions regarding Cancer Program, please contact CancerProgramsEvents@facs.org

• Surgeons
• Radiation Oncologist
• Medical Oncologist
• Surgical Oncologist
• Gynecologic Oncologist
• Pathologist

A Certificate of Completion will be awarded for this course. 
Credit is approved by the National Cancer Registrars Association (NCRA) #2025-300. for .75 contact hour.
ACS Cancer Programs is an approved provider by the California Board of Registered Nursing, provider #CEP17437,for .75 contact hour.